Evogene annual depreciation and amortization
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Evogene Depreciation & Amortization Growth & History (EVGN)
Evogene's depreciation and amortization was $1.1M for fiscal 2025.
View full Evogene company overviewEvogene annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.1M | −$237,000 | −17.16% |
| 2024 | 2024-12-31 | $1.4M | $81,000 | +6.23% |
| 2023 | 2023-12-31 | $1.3M | −$213,000 | −14.08% |
| 2022 | 2022-12-31 | $1.5M | $211,000 | +16.21% |
| 2021 | 2021-12-31 | $1.3M | −$490,000 | −27.34% |
| 2020 | 2020-12-31 | $1.8M | −$603,000 | −25.18% |
| 2019 | 2019-12-31 | $2.4M | $375,000 | +18.56% |
| 2018 | 2018-12-31 | $2.0M | −$125,000 | −5.83% |
| 2017 | 2017-12-31 | $2.1M | −$134,000 | −5.88% |
| 2016 | 2016-12-31 | $2.3M | −$154,000 | −6.33% |
| 2015 | 2015-12-31 | $2.4M | — | — |
Evogene quarterly depreciation and amortization
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $149,000 | −$96,000 | −39.18% |
| Q1 2026 | 2026-03-31 | $202,000 | −$108,000 | −34.84% |
| Q4 2025 | 2025-12-31 | $263,000 | — | — |
| Q3 2025 | 2025-09-30 | $281,000 | — | — |
| Q2 2025 | 2025-06-30 | $245,000 | — | — |
| Q1 2025 | 2025-03-31 | $310,000 | — | — |
Evogene depreciation and amortization trends
Over the last five fiscal years, Evogene's depreciation and amortization decreased from $1.8M to $1.1M, a change of −$648,000. The latest reported quarter, Q2 2026, shows $149,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evogene source filings ↗